跳至主要内容
临床试验/NCT06220981
NCT06220981招募中不适用

The Oslo Acute Reperfusion Stroke Study (OSCAR)

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2017年1月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,500
试验地点
1
主要终点
Modified Rankin Scale Score

研究概览

简要总结

Prospective registry of clinical and radiological data in acute ischemic stroke patients after endovascular treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Patients with ischemic stroke and cerebral arterial occlusion treated with endovascular revascularization.
  • All stroke severities and vascular distributions are eligible.
  • Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines.
  • Exclusion criteria:
  • Patient not eligible for the study or not available for follow-up assessments (e.g. non- resident).

排除标准

  • 未提供

结局指标

主要结局

Modified Rankin Scale Score

时间窗: 3 months

Modified Rankin Scale Score (mRS), min 0, max 6

次要结局

  • Infarct volume(1 day)
  • Incidence of symptomatic intracranial hemorrhage(1 day)
  • Volume of new areas of diffusion restriction(1 day)
  • National Institute of Health Stroke Scale Score(discharge)
  • Death due to any cause(3 months)
  • serious adverse events(3 months)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Anne Hege Aamodt

Ass. Prof.

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验